Categories

October 9, 2008 - Farr Honors Former Santa Cruz Mayor

WASHINGTON, D.C. - R. Scott Kennedy, former mayor of Santa Cruz and co-founder of the city's Resource Center for Nonviolence, was presented with the 2008 El-Hibri Peace Education Prize. This prize, including a check for $10,000, is a joint effort between Nonviolence International, American University and the El-Hibri family.

Submitted by admin on Sat, 10/17/2009 - 16:16. categories [ ]

Lebanese CEO Sees Opportunity in Current Crisis

Daily Star

July 10, 2009

http://www.dailystar.com.lb/article.asp?edition_id=1&categ_id=3&article_
id=104008



Submitted by admin on Wed, 10/14/2009 - 12:12. categories [ ]

Washington Launched Me, But I am Proud to be a Lebanese Dreaming of New Technology - Al Anwar

By Nihad Tobalian

Submitted by admin on Wed, 10/14/2009 - 12:10. categories [ ]

Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares

CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS) Fuad El-hibri sells 15,000 shares of EBS on 08/11/2009 at an average price of $16.78 a share.

Submitted by admin on Fri, 08/14/2009 - 11:41. categories [ ]

Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vacci

 OXFORD, England, ROCKVILLE, Md., & NANTES, France–(BUSINESS WIRE)–The Oxford-Emergent Tuberculosis Consortium Ltd., a joint venture between the University of Oxford and Emergent BioSolutions Inc.

Submitted by admin on Thu, 07/23/2009 - 13:42. categories [ ]

Emergent BioSolutions Buys Rival Vaccine for $2 Million

 Lansing-based Emergent BioSolutions picked up its U.S. rival’s anthrax vaccination technology for $2 million, strengthening the company’s ability to make a second anthrax vaccination.

According to excerpts from the article:

In Lansing, the acquisition of VaxGen Inc.’s vaccine could add a second product line at a new plant.

Submitted by admin on Thu, 07/23/2009 - 13:40. categories [ ]

Emergent BioSolutions hands out bonuses

 Bonus may be a bad word right now — but not for a biotech that is actually making money.

Alongside minimal pay raises, Emergent BioSolutions Inc. execs received bonuses in 2008 that increased anywhere from 5 percent to 43 percent from their 2007 bonuses. Fuad El-Hibri, chief executive of

Submitted by admin on Thu, 07/23/2009 - 13:39. categories [ ]